Follow on Google News News By Tag * Imf * Surveyed * Serbian * Health * Pharmaceutical * Cagr * th * Insurance * Finances * Cards * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | New Market Research Report: Serbia Pharmaceuticals & Healthcare Report Q1 2011New Healthcare market report from Business Monitor International: "Serbia Pharmaceuticals & Healthcare Report Q1 2011"
In the Q111 update of BMI's Pharmaceuticals and Healthcare Business Environment Ratings (BERs), Serbia continues to rank in the lower half of the index with a reduced score of 44.6 out of 100, which places the country 16th of the 20 markets surveyed in the Central and Eastern European (CEE) region. The development of the Serbian pharmaceutical market is closely linked to stability in the country's economic and political climate. Any economic or political destabilisation might negatively affect pharmaceutical market growth, as the spending power of both the state and the population would be adversely affected. Compared with other CEE countries, Serbia's political and economic situation is delicate and there are no definite time horizons in terms of its European Union (EU) accession process. In 2009, pharmaceutical imports decreased significantly by 47.4% to US$334.5mn, following an above expected increase of 30.2% y-o-y to US$636mn in 2008. However, from other available market data, BMI believes pharmaceutical expenditure at consumer prices was positive in 2009 and will continue to grow in 2010. The value of the local dinar is also a concern, although its rapid appreciation in recent years indicated that foreign investors were still willing to gamble on the potentially lucrative Serbian economy. However, as we expect dinar depreciation in the coming years, foreign activities in Serbia may become more sluggish. In September 2010, German drug company Stada Arzneimittel announced a partial halt in drug sales in Serbia, following fears over the inability of Serbian wholesalers to pay their bills. The current situation arose as state-run Serbian hospitals are either not paying or delaying their payments to wholesalers. BMI's Country Risk team are downgrading our growth outlook for Serbia's economy due to weak domestic demand and a more challenging external environment. We are now forecasting real GDP growth of just 1.8% in 2010 and have lowered our average growth forecast for 2011-2015 to 4.4% from 5.2% previously. However, we remain upbeat for Serbia's economic growth prospects over the longer term, as the country continues to converge with the EU. For more information or to purchase this report, go to: - http://www.fastmr.com/ Partial Table of Contents: Executive Summary SWOT Analysis - Serbia Pharmaceuticals And Healthcare Industry SWOT - Serbia Political SWOT - Serbia Economic SWOT - Serbia Business Environment SWOT Pharmaceutical Business Environment Ratings - Table: Emerging Europe Regional Pharma Business Environment Ratings for Q111 - Rewards - Risks Serbia - Market Summary Regulatory Regime - Table: The Number of Products on the Drugs List - Intellectual Property Environment - Pricing Regime - Price Cuts - Price Rises - Reimbursement Regime - Table: Reimbursement by ATC Categories in 2008 and 2009 - Table: Serbia - Examples of Reimbursed Medicines by Category Industry Developments - Epidemiology - Communicable Diseases - Non-Communicable Diseases - Table: Disease Burden In CEE - Healthcare Sector - Table: Serbia - Major General And Specialised Hospitals - Recent Healthcare Sector Developments - Healthcare Insurance - Healthcare Reform - Medical Tourism - Table: Serbia - Cosmetic Surgery Costs - Clinical Trials - Medical Devices - Table: Medical Device Classification In Serbia Industry Forecast Scenario - Overall Market Forecast - Table: Pharmaceutical Sales Indicators 2006-2014 - Table: Healthcare Expenditure Trends, Historical Data and Forecasts, 2006-2014 - Key Growth Factors - Macroeconomic - Table: Serbia - Economic Activity - Prescription Drug Market Forecast - Table: Serbia - Defined Daily Dose (DDD) Per 1,000 Inhabitants - Table: Prescription Drug Sales Indicators 2006-2014 - Patented Drug Market Forecast - Table: Patented Drug Sales Indicators 2006-2014 - Generic Drug Market Forecast - Table: Generic Drug Sales Indicators 2006-2014 - OTC Medicine Market Forecast - Table: Serbia - Sales Of Herbal Remedies 2007 - Table: OTC Medicine Sales Indicators 2006-2014 - Medical Device Market Forecast - Table: Medical Device Sales Indicators 2006-2014 - Pharmaceutical Trade Forecast - Table: Pharmaceutical Imports & Exports Indicators 2006-2014 - Other Healthcare Data Forecasts - Key Risks to BMI's Forecast Scenario Competitive Landscape - Investment Climate - Pharmaceutical Industry - Table: Companies Involved In The Serbian Pharmaceutical Industry - Domestic Pharmaceutical Industry - Domestic Company Activity - Foreign Pharmaceutical Industry - Table: Proposed Members Of Serbia's Pharmaceutical Industry Association - Foreign Company Activity - Pharmaceutical Wholesale And Retail - Company Monitor - Indigenous Company Profiles - Hemofarm (Stada) - Galenika - Zdravlje Actavis - Jugoremedija - Multinational Company Profiles - Pfizer - GlaxoSmithKline - Novartis - Sanofi-Aventis - Merck & Co - Krka Country Snapshot: Serbia Demographic Data - Section 1: Population - Table: Demographic Indicators, 2005-2030 - Table: Rural/Urban Breakdown, 2005-2030 - Section 2: Education And Healthcare - Table: Education, 2000/01 - Table: Vital Statistics, 2005-2030 - Section 3: Labour Market And Spending Power - Table: Employment Indicators, 2001-2006 - Full Table of Contents is available at: -- http://www.fastmr.com/ About Business Monitor International Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. View more research from Business Monitor International at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number